These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12187934)

  • 1. Vascular effects of GI262570X (PPAR-gamma agonist) in the brown adipose tissue of Han Wistar rats: a review of 1-month, 13-week, 27-week and 2-year oral toxicity studies.
    Elangbam CS; Brodie TA; Brown HR; Nold JB; Raczniak TJ; Tyler RD; Lightfoot RM; Wall HG
    Toxicol Pathol; 2002; 30(4):420-6. PubMed ID: 12187934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.
    Kelly LJ; Vicario PP; Thompson GM; Candelore MR; Doebber TW; Ventre J; Wu MS; Meurer R; Forrest MJ; Conner MW; Cascieri MA; Moller DE
    Endocrinology; 1998 Dec; 139(12):4920-7. PubMed ID: 9832429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
    Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
    Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor-gamma agonist.
    Aleo MD; Lundeen GR; Blackwell DK; Smith WM; Coleman GL; Stadnicki SW; Kluwe WM
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1173-82. PubMed ID: 12626651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine-dependent brown fat activation in rats: an immunohistochemical study.
    Giordano A; Centemeri C; Zingaretti MC; Cinti S
    Int J Obes Relat Metab Disord; 2002 Mar; 26(3):354-60. PubMed ID: 11896490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of subcutaneous sarcomas in rodents exposed to peroxisome proliferators agonists: hypothetical mechanisms of action and de-risking attitude.
    Pruimboom-Brees IM; Francone O; Pettersen JC; Kerlin RL; Will Y; Amacher DE; Boucher GG; Morton D
    Toxicol Pathol; 2012 Jul; 40(5):810-8. PubMed ID: 22504321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Nr4a1 as a cold-induced effector of brown fat thermogenesis.
    Kanzleiter T; Schneider T; Walter I; Bolze F; Eickhorst C; Heldmaier G; Klaus S; Klingenspor M
    Physiol Genomics; 2005 Dec; 24(1):37-44. PubMed ID: 16219868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPARgamma agonist.
    Petrovic N; Shabalina IG; Timmons JA; Cannon B; Nedergaard J
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E287-96. PubMed ID: 18492776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
    Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
    Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin.
    Oana F; Takeda H; Hayakawa K; Matsuzawa A; Akahane S; Isaji M; Akahane M
    Metabolism; 2005 Aug; 54(8):995-1001. PubMed ID: 16092047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2.
    Dieudonne MN; Pecquery R; Leneveu MC; Giudicelli Y
    Endocrinology; 2000 Feb; 141(2):649-56. PubMed ID: 10650946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation.
    Nugent C; Prins JB; Whitehead JP; Savage D; Wentworth JM; Chatterjee VK; O'Rahilly S
    Mol Endocrinol; 2001 Oct; 15(10):1729-38. PubMed ID: 11579205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-27 orchestrates the transcriptional regulation of brown adipogenesis.
    Sun L; Trajkovski M
    Metabolism; 2014 Feb; 63(2):272-82. PubMed ID: 24238035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.
    Hellemans K; Michalik L; Dittie A; Knorr A; Rombouts K; De Jong J; Heirman C; Quartier E; Schuit F; Wahli W; Geerts A
    Gastroenterology; 2003 Jan; 124(1):184-201. PubMed ID: 12512042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of leptin on brown and white adipose tissue.
    Siegrist-Kaiser CA; Pauli V; Juge-Aubry CE; Boss O; Pernin A; Chin WW; Cusin I; Rohner-Jeanrenaud F; Burger AG; Zapf J; Meier CA
    J Clin Invest; 1997 Dec; 100(11):2858-64. PubMed ID: 9389752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells.
    Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Kudo M; Sato K; Taniyama Y; Ito S
    Endocrinology; 2001 Jul; 142(7):3125-34. PubMed ID: 11416035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
    Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
    Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes.
    Valverde AM; Teruel T; Navarro P; Benito M; Lorenzo M
    Endocrinology; 1998 Mar; 139(3):1229-38. PubMed ID: 9492058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.